Interpace Biosciences Inc Est. EPS Q / Q
¿Qué es el Est. EPS Q / Q de Interpace Biosciences Inc?
El Est. EPS Q / Q de Interpace Biosciences Inc es -92.22%
¿Cuál es la definición de Est. EPS Q / Q?
La tasa de crecimiento prospectiva trimestral del EPS, año tras año, es el aumento estimado del EPS de la compañía para el próximo trimestre en comparación con el comportamiento de un trimestre correspondiente anterior.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q / Q de compañías en Sector Health Care en NASDAQ en comparadas con Interpace Biosciences Inc
¿Qué hace Interpace Biosciences Inc?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Empresas con est. eps q / q similar a Interpace Biosciences Inc
- Acadia Realty Trust tiene Est. EPS Q / Q de -92.31%
- Medicure tiene Est. EPS Q / Q de -92.31%
- DHT Inc tiene Est. EPS Q / Q de -92.31%
- Aleafia Health Inc tiene Est. EPS Q / Q de -92.31%
- Acacia Research Corp tiene Est. EPS Q / Q de -92.31%
- SOC Telemed tiene Est. EPS Q / Q de -92.27%
- Interpace Biosciences Inc tiene Est. EPS Q / Q de -92.22%
- Independence Contract Drilling Inc tiene Est. EPS Q / Q de -91.85%
- Frontera tiene Est. EPS Q / Q de -91.75%
- Penumbra Inc tiene Est. EPS Q / Q de -91.67%
- OrganiGram tiene Est. EPS Q / Q de -91.67%
- ShiftPixy Inc tiene Est. EPS Q / Q de -91.67%
- Smartsheet Inc tiene Est. EPS Q / Q de -91.67%